Predictors of treatment failure for adenocarcinoma in situ of the uterine cervix: Up to 14 years of recorded follow-up

The incidence of adenocarcinoma-in-situ (AIS) of the uterine cervix is rising, with invasive adenocarcinoma becoming increasingly common relative to squamous cell carcinoma. The present study reviewed a cohort of 84 patients first-time treated by conization for histologically-confirmed AIS from Janu...

Descripción completa

Detalles Bibliográficos
Autores principales: Belkić, Karen, Andersson, Sonia, Alder, Susanna, Mints, Miriam, Megyessi, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478621/
https://www.ncbi.nlm.nih.gov/pubmed/36168314
http://dx.doi.org/10.3892/ol.2022.13477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478621/
https://www.ncbi.nlm.nih.gov/pubmed/36168314
http://dx.doi.org/10.3892/ol.2022.13477

Ejemplares similares